Compounds > azomycin
Page last updated: 2024-08-21

azomycin and Cancer, Second Primary

azomycin has been researched along with Cancer, Second Primary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Alonso-Gordoa, T; Benavent, M; Capdevila, J; Custodio, A; Díez, JJ; Gajate, P; García-Carbonero, R; Grande, E; Hernando, J; Lanillos, J; López, C; Molina-Cerrillo, J; Rodriguez-Antona, C; Santos, M; Sevilla, I; Teulé, A1
Hall, EJ; Hei, TK1

Trials

1 trial(s) available for azomycin and Cancer, Second Primary

ArticleYear
Sunitinib and Evofosfamide (TH-302) in Systemic Treatment-Naïve Patients with Grade 1/2 Metastatic Pancreatic Neuroendocrine Tumors: The GETNE-1408 Trial.
    The oncologist, 2021, Volume: 26, Issue:11

    Topics: Humans; Middle Aged; Neoplasms, Second Primary; Nitroimidazoles; Pancreatic Neoplasms; Phosphoramide Mustards; Progression-Free Survival; Sunitinib

2021

Other Studies

1 other study(ies) available for azomycin and Cancer, Second Primary

ArticleYear
Oncogenic transforming potential of etanidazole.
    International journal of radiation oncology, biology, physics, 1992, Volume: 22, Issue:4

    Topics: Animals; Cell Line; Cell Transformation, Neoplastic; Etanidazole; Mice; Neoplasms, Second Primary; Nitroimidazoles; Radiation-Sensitizing Agents; Risk

1992